Navigation Links
Sigma-Aldrich Announces Collaboration With Metahelix Life Sciences
Date:7/8/2008

Partnership to provide expertise and applications support in plant

biotechnology

ST. LOUIS, July 8 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) and Metahelix Life Sciences today announced a partnership under which Metahelix will assist in developing applications data for Sigma-Aldrich's plant bioscience product line, and provide expert technological guidance regarding usage. The efforts of this collaboration will occur in Metahelix's existing facility, located adjacent to Sigma-Aldrich's manufacturing and distribution center in Bangalore, India, and provide support for Sigma-Aldrich customers throughout the Pacific Rim and Latin America.

"The plant biotechnology market is growing rapidly in Latin America and Asia as biofuels and the rapid expansion of urban centers drives increased demand for higher productivity crops," said Susan Riley, director of international business at Sigma-Aldrich. "This partnership with Metahelix is expected to enable us to support our customers with practical guidance by a firm that works with a number of different species of plants."

Guatham Nadig, head of research and development at Metahelix, said: "Metahelix will benefit from visibility of new tools available to develop our commercial offerings in the plant bioscience area."

Sigma-Aldrich serves the plant biotechnology research market with a variety of genomic and proteomic solutions, including whole genome amplification and RNA purification kits (http://www.sigmaaldrich.com/plant). The Company's leading Extract-N-Amp(TM) plant PCR technology dramatically reduces the amount of time required to extract and amplify genomic DNA from plant tissue, facilitating rapid screening. Sigma-Aldrich's SpyLine(TM) plant mRNA capture kits allow for the isolation of mRNA and performance of RT-PCR in a single 96-well PCR plate incorporating Oligo (dT) primers, eli
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sigma-Aldrich Announces Collaboration to Develop Monoclonal Antibodies
2. Sigma-Aldrich Signs Agreement With Plextronics to Distribute Plexcore(R) Organic Electronics Materials
3. Sigma-Aldrich to Present at the Nasdaq 21st Investor Program on Wednesday, May 21, 2008
4. Sigma-Aldrich (Nasdaq: SIAL) CAO & CFO Hogan Plans to Retire; Search for Successor Underway
5. Sigma-Aldrich Recognized by BioInformatics, LLC as Having the Most Useful and Easiest to Use Online and Print Catalogs
6. Sigma-Aldrich Joins Phase 2 of The RNAi Consortium to Validate shRNA Libraries
7. Sigma-Aldrich to Present at the Baird 2008 Growth Stock Conference on Tuesday, May 13, 2008
8. Sigma-Aldrich to Present at the Bank of America 2008 Healthcare Conference on Tuesday, May 13, 2008
9. Sigma-Aldrich Announces the Integration of Riedel-De Haen Into Core Product Brands
10. Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%.
11. Sigma-Aldrich Corporation 1st Quarter 2008 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... ... The 2015 Market Research Report on the Global Propanol Industry is ... with a focus on the Chinese situation. Major companies included in the propanol market ... Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , The report provides a ...
(Date:7/30/2015)... ... July 30, 2015 , ... Leading regenerative veterinary medicine company, ... canine osteoarthritis stem cell product, currently under development for FDA approval. The product ... marketed in the US by Aratana. This product, termed AT-016, is an allogeneic ...
(Date:7/30/2015)... , Inc. (NASDAQ: SNMX ), a leading company ... commercialize novel flavor ingredients for the food, beverage, and ... second quarter 2015. "Moving into the ... achieve our commercial and financial goals," stated John Poyhonen, ... our last quarterly earnings report, our two partners have ...
(Date:7/30/2015)... 2015 Ascendis Pharma A/S (Nasdaq: ... innovative TransCon technology to address significant unmet medical ... six-month Phase 2 study to evaluate the safety ... 53 treatment-naïve, pre-pubertal children with growth hormone deficiency, ... with the top-line results from our Phase 2 ...
Breaking Biology Technology:Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... Wis. StrandSoft Inc . announced on ... messaging system that allows businesses to use video ... multiple business opportunities without forcing major system alterations, ... offers, restaurant specials, hospital procedures, and health club ...
... A new kind of science is revolutionizing technology, and ... million to harness its potential during the next five ... of materials and processes at scales so small that ... microscope. These materials measure between one and 100 nanometers, ...
... about Midwest technology workplaces in this Nine2Five column, ... Midwest tech employee if you work from home doing outside ... technology is so integrated into our daily work lives nowadays ... the "bleep" noise from the machine is finished. , ,So ...
Cached Biology Technology:Online Kiosks provides a new way to send a message 2UW-Madison gets $13 million to study nanotech 2You might work in a Midwest technology environment if... 2You might work in a Midwest technology environment if... 3
(Date:7/8/2015)... July 8, 2015  Trovagene, Inc. (NASDAQ: ... today announced the launch of a study that ... Cancer Monitoring℠ (PCM) technology for predicting response to ... a combination of the novel immunotherapy agents Yervoy® ... PD-1 inhibitor. The 50-patient study will be led ...
(Date:7/7/2015)... 2015  Based on its recent analysis of ... Credence ID, LLC with the 2015 Asia-Pacific ... Year Award. Credence ID has developed a low-cost, ... of offering enrollment and identification solutions to the ... was formed by experts from the mobile biometrics ...
(Date:7/2/2015)... , June 25, 2015 ... addition of the "Next Generation Biometrics Market by ... 2020" report to their offering. The ... Billion by 2020, at a CAGR of 17.9% between ... the leading application for the market. Safran SA ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3
... London, containing more than a dozen skeletons of people ... are thought to have died during the 14th century ... the site. The Plague is by definition ... is highly contagious, leading to mass outbreaks across populations. ...
... the Max Planck Institute for Polymer Research (MPI-P) in ... a mineral content of almost 90 percent, yet extremely ... sea sponges and recreated the sponge spicules using the ... sponge. Natural minerals are usually very hard and prickly, ...
... living in the Nebraska Sandhills, color can literally be the ... colonized the region, the dark-coated mice stood out starkly against ... Over the next 8,000 years, however, the mice evolved a ... stripe on their tails and changes in the extent of ...
Cached Biology News:Inspired by deep sea sponges: Creating flexible minerals 2One gene, many mutations 2One gene, many mutations 3
Chicken Anti-Human DNA-directed RNA Polymerase II 7.6 Kd Polypeptide (POLR2L Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: ELISA, Western Blot...
The BD CBA Human Apoptosis Kit can be used to quantitatively measure,cleaved PARP, Bcl-2, and active Caspase-3 protein levels in a single sample. The,Kit performance has been optimized for analysis o...
... proteases/caspases initiates apoptosis in mammalian cells. ... provides a simple and convenient means for ... in intact cells. The assay utilizes ... linked to rhodamine 110 (D2R), a reported ...
The PROTEAN II slab gel casting stand is a component of the PROTEAN II XL and xi casting apparatus. It is supplied with gaskets....
Biology Products: